Transgenic mouse models in carcinogenesis: Interaction of c-myc with transforming growth factor a and hepatocyte growth factor in hepatocarcinogenesis

British Journal of Clinical Pharmacology

Volumn 42, Issue 1, 1996, Pages 43-52

  Thorgeirsson, Snorri S ^a   Santoni Rugiu, Eric ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Carcinogenesis; Oncogenes; Suppressor genes; Transgenic mouse

Indexed keywords

PHENOBARBITAL; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; CARCINOGENESIS; CONFERENCE PAPER; CONTROLLED STUDY; GENE EXPRESSION; LIVER CANCER; MOUSE; NONHUMAN; NORTHERN BLOTTING; ONCOGENE C MYC; PHENOTYPE; PRIORITY JOURNAL; SUPPRESSOR GENE; TRANSGENIC MOUSE;

EID: 0029901652     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1996.03748.x     Document Type: Conference Paper

References (84)

1. Bishop JM. The molecular genetics of cancer. Science 1987; 235: 305-308.
2. Bishop JM. Molecular themes in ontogenesis. Cell 1991; 64: 235-248.
3. Hunter T. Cooperation between oncogenes. Cell 1991; 64: 249-270.
4. Fearon EF, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-767.
5. Compere SJ, Baldacci P, Jaenisch R. Oncogenes in transgenic mice. Biochim Biophys Acta 1988; 948: 129-149.
6. Hanahan D. Dissecting multistep tumorigenesis in transgenic mice. Ann Rev Genet 1988; 22: 479-519.
7. DePinho RA, Schreiber-Agus N, Alt FW. Myc family oncogenes in development of normal and neoplastic cells. Adv Cancer Res 1991; 57: 1-46.
8. Luscher B, Eisenman RN. New light on myc and myb. Part. I. Myc. Genes Dev 1990; 4: 2025-2035.
9. Moroy T, Alt FW, DePinho RA. Use of transgenic mice to study normal and abnormal mammalian development. In Molecular Foundation of Oncology, eds Broder S, et al., Baltimore, MD: Williams and Wilkins, 1991: 455-487.
10. Chandar N, Lombardi B, Locker J. c-Myc gene amplification during hepatocarcinogenesis by a choline-devoid diet. Proc. Natl Acad Sci USA, 1989; 86: 2703-2707.
11. Yaswen P, Goyette M, Shank PR, Fausto N. Expression of c-Ki-ras, c-Ha-ras and c-myc in specific cell types during hepatocarcinogenesis. Mol Cell Biol 1985; 5: 780-786.
12. Ren GJ, Hu LF, Cheng YC, Wan DF. Oncogenes in human primary hepatic cancer. J Cell Physiol Suppl 1986; 4: 13-21.
13. Nagy P, Evarts RP, Marsden E, Roach J. Thorgeirsson SS. Cellular distribution of c-myc transcripts during chemical hepatocarcinogenesis in rats. Cancer Res 1988; 48: 5522-5527.
14. Derynck R, Goeddel DV, Ullrich A. et al. Synthesis of messenger RNAs for transforming growth factors α and β and the epidermal growth factor receptor by human tumours. Cancer Res 1987; 47: 707-712.
15. Liu C, Tsao MS, Grisham JW. Transforming growth factors produced by normal and neoplastically transformed rat liver epithelial cells in culture. Cancer Res 1988; 48: 850-855.
16. Raymond VW, Lee DC, Grisham JW, Earp HS. Regulation of transforming growth factor α messenger RNA expression in a chemically transformed rat hepatic epithelial cell line by phorbol ester and hormones. Cancer Res 1989; 49: 3608-3612.
17. Marquardt H, Hunkapillar MW, Hood LE, et al. Transforming growth factors produced by retrovirus-transformed rodent fibroblasts and human melanoma cells: amino acid sequence homology with epidermal growth factor. Proc Natl Acad Sci USA 1983; 80: 4684-4688.
18. Massague J. Epidermal growth factor-like transforming growth factor II. Interaction with epidermal growth factor receptors on human placenta membrane and A431 cells. J Biol Chem 1983; 258: 13614-13620.
19. Marquardt H, Hunkapillar MW, Hood LE, Todaro GJ. Rat transforming growth factor type I: structure and relation to epidermal growth factor. Science 1984; 223: 1079-1082.
20. Sandgren EP, Quaife CJ, Pinkert CA, Palmiter RD, Brinster RL. Oncogene-induced liver neoplasia in transgenic mice. Oncogene 1989; 4: 715-724.
21. Perraud F, Dalemans W, Genrault JL, et al. Characterization of trans-immortalized hepatic cell lines established from transgenic mice. Exp Cell Res 1991; 195: 59-65.
22. Jhappan C, Stahle C, Harkins RN, Fausto N, Smith GH, Merlino GT. TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 1990; 61: 1137-1146.
23. Sandgren EP, Luetteke NC, Palmiter RD, Brinster RL, Lee DC. Overexpression of TGFα in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 1990; 61: 1121-1135.
24. Takagi H, Jhappan C, Sharp R, Merlino G. Hypertrophic gastropathy resembling Menetrier's disease in transgenic mice overexpressing transforming growth factor alpha in the stomach. J Clin Invest 1991; 90: 1161-1167.
25. Michalopoulos GK, Houck KA, Dolan ML, Luetteke NC. Control of hepatocyte proliferation by two serum factors. Cancer Res 1984; 44: 4414-4419.
26. Nakamura T, Nawa K, Ichiara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 1984; 122: 1450-1459.
27. Wolf HK, Zarnegar R, Michalopoulos GK. Localization of hepatocyte growth factor in human and rat tissues: an immunohistochemical study. Hepatology 1991; 14: 488-494.
28. Hu Z, Evarts RP, Fujio K, Marsden ER, Thorgeirsson SS. Expression of hepatocyte growth factor and c-met genes during hepatic differentiation and liver development in the rat. Am J Pathol 1993; 142: 1823-1830.
29. Sakaguchi H, Seki S, Tsubouchi H, et al. Ultrastructural location of human hepatocyte growth factor in human liver. Hepatology 1994; 19: 1157-1163.
30. Stoker M, Gherardi E, Perryman M, Gray J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 1987; 327: 239-242.
31. Weidner KM, Arakaki N, Hartmann G, et al. Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci USA 1991; 88: 7001-7005.
32. Naldini L, Weidner KM, Vigna E, et al. Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. EMBO J 1991; 10: 2867-2878.
33. Strain A, Ismail T, Tsubouchi H, et al. Native and recombinant human hepatocyte growth factors are highly potent promoters of DNA synthesis in both human and rat hepatocytes. J Clin Invest 1991; 87: 1853-1857.
34. Matsumoto K, Nakamura T. Roles of HGF as a pleiotropic factor in organ regeneration. In Hepatocyte Growth Factor-Scatter Factor (HGF-SF) and c-Met Receptor. eds. Goldberg ID, Rosen EM. Birkhäuser: Verlag, Basel, 1993: 225-249.
35. Bussolino F, Di Renzo MF, Ziche M, et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 1992; 119: 629-641.
36. Grant DS, Kleinman HK, Goldberg, ID et al. Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA 1993; 90: 1937-1941.
37. Zarnegar R, Michalopoulos GK. The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J Cell Biol 1995; 129: 1177-1180.
38. Pepper MS, Matsumoto K, Nakamura T, Orci L, Montesano R. Hepatocyte growth factor increases urokinase-type plasminogen activator (u-PA) and u-PA receptor expression in Madin-Darby canine epithelial cells. J Biol Chem 1992; 267: 20493.
39. Wojta J, Nakamura T, Fabry A. et al. Hepatocyte growth factor stimulates expression of plasminogen activator inhibitor type 1 and tissue factor in HepG2 cells. Blood 1994; 84: 151-157.
40. Michalopoulos GK, Appasamy R. Metabolism of HGF-SF and its role in liver regeneration. In Hepatocyte Growth Factor-Scatter Factor (HGF-SF) and c-Met Receptor, eds Goldberg ID, Rosen EM. Birkhäuser Verlag, Basel, 1993: 175-283.
41. Aldana PR, Goerke ME, Carr SC, Tracy TF Jr. The expression of regenerative growth factors in chronic liver injury and repair. J Surg Res 1994; 57: 711-717.
42. Rosen EM, Nigam SK, Goldberg ID. Scatter Factor and the c-Met receptor: a paradigm for mesenchymal/epithelial interaction. J Cell Biol 1994; 127: 1783-1787.
43. Schmidt C, Bladt F, Goedecke S, et al. Scatter factor hepatocyte growth factor is essential for liver development. Nature 1995; 373: 699-702.
44. Uehara Y, Uehara Y, Minowa O, et al. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 1995; 373: 702-705.
45. Bottaro DP, Rubin JS, Faletto DL, et al. Identification of the HGF receptor as the c-Met proto-oncogene product. Science 1991; 251: 802-804.
46. Comoglio PM. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells. In Hepatocyte Growth Factor-Scatter Factor (HGF-SF) and c-Met receptor, eds Goldberg ID, Rosen EM. Birkhäuser Verlag, Basel. 1993: 131-165.
47. Weidner KM, Sachs M, Birchmeier W. The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells. J Cell Biol 1993; 127: 145-154.
48. Prat M, Narsimhan RP, Crepaldi T, et al. The receptor encoded by the human c-met oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int J Cancer 1991; 49: 323-328.
49. Rong S, Bodescot M, Blair D, et al. Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor. Mol Cell Biol 1992; 12: 5152-5158.
50. Di Renzo MF, Olivero M, Ferro S, et al. Overexpression of the c-met/HGF receptor gene in human thyroid carcinomas. Oncogene 1992; 7: 2549-2553.
51. Kuniyasu H, Yasui W, Yokozaki H, Kitadai Y, Tahara E. Aberrant expression of c-met mRNA in human gastric carcinomas. Int J Cancer 1993; 55: 72-75.
52. Tsao MS, Zhu H, Giaid A, et al. Hepatocyte growth factor/scatter factor is an autocrine factor for human normal bronchial epithelial and lung carcinoma cells. Cell Growth Differ 1993; 4: 571-579.
53. Ebert M, Yokoyama M, Friess H, Büchler MW, Korc M. Coexpression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer. Cancer Res 1994; 54: 5775-5778.
54. Natala PG, Nicotra MR, Di Renzo MF, et al. Expression of the c-met/HGF receptor in human melanocytic neoplasms: demonstration of the relationship to malignant melanoma tumour progression. Br J Cancer 1993; 68: 746-750.
55. Bellusci S, Moens G, Gaudino G, et al. Creation of an hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increase tumorigenicity. Oncogene 1994; 9: 1091-1099.
56. Rong S, Segal S, Anver M, Resau JH, Vande Woude GF. Invasiveness and metastasis of NIH/3T3 cells induced by Met-HGF/SF autocrine stimulation. Proc Natl Acad Sci USA 1994; 91: 4731-4735.
57. Di Renzo MF, Olivero M, Giacomini A, et al. Overexpression and amplilication of the met/HGF receptor gene during progression of colorectal cancer. Clin Cancer Res 1995; 1: 147-154.
58. Rong S, Donehower LA, Hansen MF, et al. Met protooncogene product is overexpressed in tumors of p53-deficient mice and tumors of Li-Fraumeni patients. Cancer Res 1995; 55: 1963-1970.
59. Higashio K, Shima N, Goto M, et al. Identity of a tumor cytotoxic factor from human fibroblasts and hepatocyte growth factor. Biochem Biophys Res Commun 1990; 170: 397-404.
60. Tajima H, Matsumoto K, Nakamura T. Hepatocyte growth factor has a potent anti-proliferalive activity in various tumor cell lines. FEBS Lett 1991; 291: 229-232.
61. Shima N, Nagao M, Ogaki F, et al. Tumor cytotoxic factor/hepatocyte growth factor from human fibroblasts: cloning of its cDNA, purification and characterization of recombinant protein. Biochem Biophys Res Commun 1991; 180: 1151-1158.
62. Shiota G, Rhoads DB, Wang TC, Nakamura T, Schmidt EV. Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells. Proc Natl Acad Sci USA 1992; 89: 373-377.
63. Shiota G, Kawasaki H, Nakamura T, Schmidt EV. Inhibitory effect of hepatocyte growth factor against FaO hepatocellular carcinoma cells may be associated with changes of intracellular signaling pathways mediated by protein kinase C. Res Commun Mol Pathol Pharmacol 1994; 85: 271-278.
64. Liu ML, Mars WM, Michalopoulos GK. Hepatocyte growth factor inhibits cell proliferation in vivo of rat hepatocellular carcinomas induced by diethylnitrosamine. Cardinogenesis 1995; 16: 841-843.
65. James NH, Roberts RA. The peroxisome proliferator class of non-genotoxic hepatocarcinogens synergize with epidermal growth factor to promote clonal expansion of initiated rat hepatocytes. Carcinogenesis 1994; 15: 2687-2694.
66. Shiota G, Wang TC, Nakamura T, Schmidt EV. Hepatocyte growth factor in transgenic mice: effects on hepatocyte growth, liver regeneration and gene expression. Hepatology 1994; 19: 962.
67. Murakami H, Sanderson ND, Nagy P, et al. Transgenic model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor α in hepatic oncogenesis. Cancer Res 1993; 53: 1719-1723.
68. Gentry LE, Twardzik DR, Lim GJ, Ranchalis JE, Lee DC. Expression and characterization of transforming growth factor α precursor protein in transfected mammalian cells. Mol Cell Biol 1987; 7: 1585-1591.
69. Evarts RP, Nakatsukasa H, Marsden ER, Hu Z, Thorgeirsson SS. Expression of transforming growth factor-alpha in regenerating liver and during hepatic differentiation. Mol Carcinog 1992; 5: 25-31.
70. Wright NA, Poulsom R, Stamp GWH, et al. Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. J Pathol 1990; 162: 279-284.
71. Tuczek HU, Grau FA, Mischlinsky A, Wagner T, Wegner G. Distribution of albumin in normal and regenerating livers of mice. Histochemistry 1985; 83: 165-169.
72. Frith CH, Ward JM, Turosov VS. Tumors of the liver. In Pathology of Tumours in Laboratory Animals, eds Turosov V, Mohr U, vol. 2, IARC Scientific Publications, Lyon, 1994: 223-270.
73. Bursch W, Lauer B. Timmermann-Trosiener I, et al. Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis 1984; 5: 453-458.
74. Jirtle RL, Meyer SA. Liver tumor promotion: effect of phenobarbital on EGF and protein kinase C signal transduction and transforming growth factor-β1 expression. Dig Dis Sci 1991; 36: 659-668.
75. Neveu MJ, Babcock KL, Hertzberg EL, et al. Colocalized alterations in connexin 32 and cytochrome P450IIB1/2 by phenobarbital and related liver tumor promoters. Cancer Res 1994; 54: 3145-3152.
76. Jirtle RL, Hankins GR, Reisenbichler H, Boyer IJ. Regulation of mannose 6-phosphate/insulin-like growth factor-II receptors and transforming growth factor beta during liver tumor promotion with phenobarbital. Carcinogenesis 1994; 15: 1473-1478.
77. Seglen PO, Saeterm G, Schwarze PE. Liver tumor promoters stimulate growth of transplanted hepatocellular carcinomas. Hepatology 1990; 12: 295-300.
78. Takagi H, Sharp R, Takayama H, et al. Collaboration between growth factors and diverse chemical carcinogens in hepatocarcinogenesis of transforming growth factor α transgenic mice. Cancer Res. 1993; 53: 4329-4336.
79. Lindroos P, Tsai WT, Zarnegar R, Michalopoulos GK. Plasma levels of HGF in rats treated with tumors promoters. Carcinogenesis 1992; 13: 139-141.
80. Lindroos P, Michalopoulos GK. Response of phenobarbital- and ciprofibrate-exposed hepatocytes to growth factors in type I collagen gels. Carcinogenesis 1993; 14: 731-735.
81. Schirmacher P, Held WA, Yang D, Biempica L, Rogler CE. Selective amplification of periportal transitional cells precedes formation of hepatocellular carcinoma in SV40 large tag transgenic mice. Am J Pathol 1991; 139: 231-241.
82. Nagy P, Evarts RP, Marsden E, Roach J, Thorgeirsson SS. Cellular distribution of c-myc transcripts during chemical carcinogenesis in rats. Cancer Res 1988; 48: 5522-5527.
83. Grigioni WF, Fiorentino M, D'Errico A, et al. Overexpression of c-met protooncogene product and raised Ki67 index in hepatocellular carcinomas with respect to benign conditions. Hepatology 1995; 21: 1543-1546.
84. Iyer A, Kmiecik TE, Park M, et al. Structure, tissue-specific expression, and transforming activity of the mouse met protooncogene. Cell Growth Differ 1990; 1: 87-95.